TTrialPathMatch Me to Trials
← Back to trials
RecruitingLiver CancerLiver Metastases

DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.

Eligible age

18+ yrs

Accepts

All genders

Locations

3 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The DRAGON registry aims to collect data on combined portal and hepatic vein embolization (PVE/HVE) for liver tumors, a technique expected to enhance liver regeneration compared to standard PVE. This collaborative registry focuses on identifying associations between baseline clinical/imaging parameters, clinical outcomes, and safety for patients undergoing PVE/HVE.

Sponsor: Maastricht University Medical Center

You may qualify if…

  • Patients who have undergone PVE/HVE or technical variations on this procedure
  • 18 Years and older
  • Men and women

Where it's recruiting

Illinois

Chicago

Minnesota

Rochester

Ohio

Cleveland

Source: ClinicalTrials.gov · NCT07717437 · last updated 2026-07-21

DRAGON Registry - International Multicenter Registry and Medical Image · TrialPath